David A. Siegel Syros Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.69 - $1.21 $73,623 - $129,107
-106,700 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.02 - $3.8 $16,422 - $61,180
16,100 Added 17.77%
106,700 $127,000
Q4 2021

Feb 14, 2022
SELL
$3.26 - $4.66 $267,646 - $382,586
-82,100 Reduced 47.54%
90,600 $295,000
Q3 2021

Nov 15, 2021
SELL
$4.08 - $5.66 $340,272 - $472,044
-83,400 Reduced 32.57%
172,700 $772,000
Q2 2021

Aug 16, 2021
SELL
$5.01 - $7.48 $198,897 - $296,956
-39,700 Reduced 13.42%
256,100 $1.4 Million
Q1 2021

May 17, 2021
BUY
$7.19 - $14.95 $467,350 - $971,750
65,000 Added 28.16%
295,800 $2.21 Million
Q4 2020

Feb 16, 2021
BUY
$6.66 - $14.66 $324,342 - $713,942
48,700 Added 26.74%
230,800 $2.5 Million
Q3 2020

Nov 16, 2020
SELL
$8.69 - $14.47 $1,738 - $2,894
-200 Reduced 0.11%
182,100 $1.61 Million
Q2 2020

Aug 14, 2020
BUY
$5.21 - $11.03 $530,899 - $1.12 Million
101,900 Added 126.74%
182,300 $1.94 Million
Q1 2020

May 15, 2020
SELL
$4.46 - $9.2 $111,946 - $230,919
-25,100 Reduced 23.79%
80,400 $477,000
Q4 2019

Feb 14, 2020
BUY
$4.52 - $10.1 $476,859 - $1.07 Million
105,500 New
105,500 $729,000
Q3 2019

Nov 14, 2019
SELL
$7.14 - $11.65 $271,320 - $442,700
-38,000 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$5.5 - $9.75 $16,500 - $29,250
-3,000 Reduced 7.32%
38,000 $352,000
Q1 2019

May 15, 2019
SELL
$5.51 - $9.59 $53,998 - $93,982
-9,800 Reduced 19.29%
41,000 $375,000
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $25,530 - $52,164
-4,600 Reduced 8.3%
50,800 $283,000
Q3 2018

Nov 14, 2018
SELL
$9.74 - $12.92 $181,164 - $240,312
-18,600 Reduced 25.14%
55,400 $660,000
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $751,840 - $1.01 Million
74,000 New
74,000 $756,000
Q1 2018

May 15, 2018
SELL
$9.47 - $12.98 $102,276 - $140,184
-10,800 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$8.45 - $17.48 $91,259 - $188,784
10,800
10,800 $105,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $5.67M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email